Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.

Publication Type:

Journal Article

Source:

Stroke; a journal of cerebral circulation, Volume 43, Issue 4, p.952-7 (2012)

Keywords:

2012, Activated Protein C Resistance, Aged, Brain Ischemia, Female, Follow-Up Studies, Hormone Replacement Therapy, Humans, Lipoproteins, May 2012, Middle Aged, Postmenopause, Protein C, Public Health Sciences Division, Retrospective Studies, Risk Factors, Stroke

Abstract:

To test whether changes in plasma tissue factor pathway inhibitor (TFPI) levels or activated protein C resistance (normalized activated protein C resistance ratio [nAPCsr]) modify the increased risk of ischemic stroke due to postmenopausal hormone therapy.